Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 July, 2018 19:10 IST
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
Source: IRIS | 12 Jul, 2018, 01.23PM
Comments  |  Post Comment

Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is "closed" and states that the inspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from April 5 to 12, 2018.

Shares of the company declined Rs 3, or 0.81%, to trade at Rs 368.50. The total volume of shares traded was 107,976 at the BSE (1.09 p.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
ACC quarterly earnings rise 0.92% - 23-Jul-2018 17:10
Maruti Suzuki achieves production milestone in India - 23-Jul-2018 16:35
Welspun Corp quarterly earnings decline 14% - 23-Jul-2018 15:54
Hindustan Zinc quarterly earnings up 1.5% - 23-Jul-2018 15:33
Hindustan Oil Exploration quarterly net soars 7.95 times - 23-Jul-2018 15:25
Vijaya Bank quarterly earnings plunges 43% - 23-Jul-2018 15:11
Sterlite Technologies arm completes acquisition of Metallurgica Bresciana - 23-Jul-2018 12:33
Suven participates at Alzheimer's Association International Conference - 23-Jul-2018 12:14
HDFC Bank quarterly net climbs 18% to Rs 46.01 bn - 23-Jul-2018 10:48
Thomas Cook inks long term pact with Seoul Tourism - 23-Jul-2018 10:33
CG Power & Industrial Solutions sells biz in Hungary - 23-Jul-2018 09:54
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer